- Trials with a EudraCT protocol (19)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
19 result(s) found for: Degenerative disc disease.
Displaying page 1 of 1.
EudraCT Number: 2010-023830-22 | Sponsor Protocol Number: AAG-G-H-1102 | Start Date*: 2012-05-23 | |||||||||||
Sponsor Name:TETEC AG | |||||||||||||
Full Title: NDisc Study: A Prospective Randomized Multicentre Phase I / II Clinical Trial to Evaluate Safety and Efficacy of NOVOCART® Disc plus Autologous Disc Chondrocyte Transplantation (ADCT) in the Treatm... | |||||||||||||
Medical condition: The subject has a disc herniation with back and /or leg pain (radicular pain) and an identification for sequestrectomy according to the guidelines of DGNC and DGOOC. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004444-30 | Sponsor Protocol Number: Disc_allo_MSV | Start Date*: 2013-04-23 |
Sponsor Name:Citospin | ||
Full Title: Treatment of degenerative disc disease with allogenic mesenchymal cells—MSV-- | ||
Medical condition: Treatment of degenerative disc disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012672-27 | Sponsor Protocol Number: CIP0702PLF/EU | Start Date*: 2009-08-17 | |||||||||||
Sponsor Name:ApaTech Limited | |||||||||||||
Full Title: "A prospective, randomised study comparing the use of Actifuse™ ABX synthetic bone substitute with INFUSE® in patients requiring posterolateral instrumented lumbar fusion with interbody fusion" als... | |||||||||||||
Medical condition: Prospective trial participants will have been diagnosed with degenerative disc disease with a treatment option of decompression and Interbody Fusion with Posterolateral Intertransverse Process Fusi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000860-14 | Sponsor Protocol Number: GR-OG-279239-03 | Start Date*: 2018-02-27 | |||||||||||
Sponsor Name:Genera Research Ltd | |||||||||||||
Full Title: Patient and evaluator blinded non-inferiority study on safety, tolerability and lumbar fusion efficacy of a single administration of Osteogrow (rhBMP6 in autologous blood coagulum (ABC) carrier) in... | |||||||||||||
Medical condition: Lumbar spine single segment destabilization caused by degenerative disc disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005766-36 | Sponsor Protocol Number: | Start Date*: 2006-11-17 |
Sponsor Name:Sofamor - Danek | ||
Full Title: A Randomized Prospective Study of Instrumented Posterior Lumbar Interbody Fusion: Autologous Iliac Crest Bone Graft vs. Inductos™ | ||
Medical condition: We will investigate if the use of Inductos in a intervertebral cage will provide us with better and or faster fusion rates. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004480-31 | Sponsor Protocol Number: ALLOB-IF1 | Start Date*: 2014-05-27 | |||||||||||
Sponsor Name:Bone Therapeutics S.A. | |||||||||||||
Full Title: A Pilot Phase IIa, Multicentre, Open, Proof-of-concept Study on the Safety and the Efficacy of Allogeneic Osteoblastic Cells (ALLOB®) implantation in Lumbar Spinal Fusion | |||||||||||||
Medical condition: Degenerative disc disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002749-40 | Sponsor Protocol Number: DREAM-GR-2018-12367168 | Start Date*: 2019-12-02 | |||||||||||
Sponsor Name:UNIVERSITÀ CAMPUS BIO-MEDICO DI ROMA | |||||||||||||
Full Title: Intervertebral Disc REgeneration mediated by Autologous Mesenchymal stem/stromal cells intradiscal injection: a phase IIB randomized clinical trial. | |||||||||||||
Medical condition: Symptomatic chronic low back pain due to a degenerative disease of the intervertebral disc | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024665-52 | Sponsor Protocol Number: AMSC-DSD-001 | Start Date*: 2013-07-24 | |||||||||||
Sponsor Name:Bioinova, s.r.o. | |||||||||||||
Full Title: Utilization of Autologous Mesenchymal Cells in Posterolateral Spinal Fusion in Degenerative Spine Disease: a Prospective, Non-randomized, Open-Label Study to Assess the Safety and the Efficacy. | |||||||||||||
Medical condition: Spinal degenerative disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002092-25 | Sponsor Protocol Number: 9766 | Start Date*: 2018-06-18 |
Sponsor Name:University Hospital of Montpellier | ||
Full Title: A phase 2/3 prospective, multicentre randomized, double-blind trial, comparing intra-discal allogeneic adult BM-MSC therapy and sham-treated controls in subjects with chronic low back pain due to l... | ||
Medical condition: Degenerative Disc Disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) FR (Completed) DE (Trial now transitioned) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021662-30 | Sponsor Protocol Number: CRFB002F2301 | Start Date*: 2010-11-05 | |||||||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||||||||||||
Full Title: A 12 month, phase III, randomized, double-masked, multi-center, active-controlled study to evaluate the efficacy and safety of two different dosing regimens of 0.5 mg ranibizumab vs. verteporfin PD... | |||||||||||||||||||||||
Medical condition: visual impairment due to choroidal neovascularization secondary to pathologic myopia | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: PT (Completed) LV (Completed) HU (Completed) LT (Completed) FR (Completed) ES (Completed) IT (Completed) AT (Completed) SK (Completed) DE (Completed) GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004476-19 | Sponsor Protocol Number: ACTIVE-BRIC2018–ID03 | Start Date*: 2020-04-28 | |||||||||||
Sponsor Name:UNIVERSITÀ CAMPUS BIO-MEDICO DI ROMA | |||||||||||||
Full Title: Autologous mesenchymal stem/stromal Cells for the Treatment of workers affected by chronic low back pain due to multilevel InterVErtebral disc degeneration: a phase IIB randomized clinical trial - ... | |||||||||||||
Medical condition: Symptomatic chronic low back pain due to a degenerative disease of the intervertebral disc | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002642-23 | Sponsor Protocol Number: NVD-CLN01 | Start Date*: 2016-11-28 |
Sponsor Name:Novadip Biosciences | ||
Full Title: A prospective multi-centre, randomised, controlled study to evaluate the safety and preliminary effectiveness of NVD-001 for the treatment of low grade degenerative lumbar spondylolisthesis by inte... | ||
Medical condition: Patients diagnosed with symptomatic degenerative spondylolisthesis grade I or II with an indication for spinal fusion of one vertebral segment (L1-S1). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) PL (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001146-29 | Sponsor Protocol Number: 1 | Start Date*: 2016-01-12 |
Sponsor Name:Hospital Central de la Defensa | ||
Full Title: Selective local anesthesia versus a combined medication injection with corticosteroids in degenerartive spine | ||
Medical condition: Degenerative spine pain when there are no indications for surgical treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005645-27 | Sponsor Protocol Number: DBM | Start Date*: 2009-06-26 |
Sponsor Name:Medizinische Universität Innsbruck, vertreten durch Univ. Prof. Dr. Martin Krismer | ||
Full Title: Vergleich von demineralisierter Knochenmatrix (DBM) und Knochenallograft bei der anterioren lumbale Wirbelkörperfusion (ALIF) mittels Synfix LR | ||
Medical condition: Anteriore lumbale Wirbelkörperfusion (Anterior lumbar interbody fusion, ALIF) ist ein Standardverfahren bei der operative Behandlung von chronischem Kreuzschmerz und zur Fusion bei degenerativen ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-000675-34 | Sponsor Protocol Number: EU 101 | Start Date*: 2004-12-21 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: A Prospective, Randomized, Controlled, Multi-center, (Pilot) Study of Osigraft® in Instrumented Posterolateral Fusions | ||
Medical condition: Subjects qualifying for decompression and fusion of one spinal level (L3-S1) with the use of autograft will be recruited through the medical institutions of participating investigators. All subject... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004269-96 | Sponsor Protocol Number: IG8801CLBP201 | Start Date*: 2016-02-24 | |||||||||||
Sponsor Name:Gador S.A. | |||||||||||||
Full Title: A 24 weeks multicentre, randomized, double-blind, placebo-controlled, parallel group, study to evaluate the efficacy, safety and tolerability of intravenous IG-8801 20 mg and 40 mg in subjects with... | |||||||||||||
Medical condition: non-specific Chronic Low Back Pain persisting for at least 3 months | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001160-38 | Sponsor Protocol Number: lidocaineplif | Start Date*: 2014-01-08 | |||||||||||||||||||||
Sponsor Name:ZNA Middelheim | |||||||||||||||||||||||
Full Title: Impact of intravenous lidocaine infusion on postoperative analgesia for one or two level posterior lumbar interbody fusion surgery | |||||||||||||||||||||||
Medical condition: The postoperative pain intensity after posterior interbody fusion surgery is often intense and difficult to treat with IV morphine and paracetamol alone. Besides, the use of opioids is often associ... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005722-35 | Sponsor Protocol Number: H--6-2014-070 | Start Date*: 2015-06-23 | ||||||||||||||||
Sponsor Name:Glostrup University Hospital | ||||||||||||||||||
Full Title: Measures of inflammation in low back pain (LBP) and anti-TNFα for the treatment of deemed discogenic LBP - an explorative study | ||||||||||||||||||
Medical condition: Low back pain with and without legg-pain In the late periode 1990ies it became clear that various cytokines and other inflammatory elements played a large role for low back pain. One of the known ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000422-36 | Sponsor Protocol Number: SB11-G31-AMD | Start Date*: 2017-11-28 | |||||||||||
Sponsor Name:Samsung Bioepis Co., Ltd. | |||||||||||||
Full Title: A Phase III Randomised, Double-masked, Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity between SB11 (proposed ranibizumab biosimilar) and Luce... | |||||||||||||
Medical condition: Neovascular Age-related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) HU (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
